The Darzalex Faspro market is witnessing steady growth over the forecast period, supported by increasing multiple myeloma diagnosis rates, expansion of outpatient oncology care.
Read More
The Daratumumab Or Darzalex market is witnessing steady growth over the forecast period, supported by expansion of combination regimens, growing multiple myeloma prevalence.
Read More
The Daptacel market is witnessing steady growth over the forecast period, supported by continued expansion of pediatric healthcare access, stronger disease surveillance.
Read More
The Danyelza market is witnessing steady growth over the forecast period, supported by growth in pediatric cancer trials, expansion of immuno oncology pipelines.
Read More
The Cytogam (Cytomegalovirus Immune Globulin Intravenous) market is witnessing steady growth over the forecast period, supported by growth in transplant volumes, increasing immunosuppressed.
Read More
The Cyramza (Ramucirumab) market is witnessing steady growth over the forecast period, supported by increasing incidence of solid tumors, expansion into new oncology indications.
Read More
The Cyfendus market is witnessing steady growth over the forecast period, supported by heightened biodefense investments, expansion of emergency response frameworks.
Read More
The Cuvitru market is witnessing steady growth over the forecast period, supported by expansion of home healthcare immunotherapy, rising demand for convenient self-administration options.
Read More
The Cutaquig market is witnessing steady growth over the forecast period, supported by growth of home infusion models, rising immune disorder prevalence.
Read More
The Curosurf (Poractant Alfa) market is witnessing steady growth over the forecast period, supported by increasing premature birth rates globally, expansion of nicu infrastructure.
Read More